{"product_id":"donotage-nitralis-review","title":"DoNotAge Nitralis Review: Trial, Formula \u0026 Benefits","description":"\u003csection class=\"bb-nitralis-review\"\u003e\n\u003cp\u003e\u003cstrong\u003eBiohack Blueprint's featured branded nitric oxide booster.\u003c\/strong\u003e DoNotAge Nitralis stands out for a reason that matters in this category: it has a published randomized, placebo-controlled human study of the \u003cem\u003efinished proprietary formula\u003c\/em\u003e, not merely a collection of citations about unrelated ingredients. In its 30-day pilot, 60.5% of Nitralis users reached the prespecified salivary test-strip response threshold, compared with 11.9% of placebo users. This is a meaningful product-specific research starting point for a supplement buyer, although saliva-strip changes are not the same as proven improvements in blood pressure or other clinical outcomes. \u003ca href=\"\/blogs\/nitric-oxide\/nitralis-clinical-trial\"\u003eExplore our full trial appraisal\u003c\/a\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEditorial product rating: 4.8\/5.\u003c\/strong\u003e This rating reflects our appraisal of finished-formula human research, the rationale for the three-ingredient combination, product usability and research traceability. It does not represent a measured 4.8\/5 clinical efficacy result or an independently established comparison of every nitric oxide booster on the market.\u003c\/p\u003e\n\u003ch2\u003eWhat makes Nitralis different?\u003c\/h2\u003e\n\u003cp\u003eMany nitric oxide supplement formulas draw on general studies of beetroot, isolated amino acids or botanicals. Nitralis goes an important step further by publishing a trial of its own proprietary blend. In a market where ingredient-only evidence is frequently used to market finished products, direct product-specific research is a useful differentiator. That does not make different trials interchangeable: the published Nitralis study assessed a salivary biomarker, while standardized beetroot trials have separately investigated blood pressure and exercise outcomes.\u003c\/p\u003e\n\u003ch2\u003eHow its three ingredients fit together\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eFermented beet — the nitrate-pathway foundation.\u003c\/strong\u003e Nitrate from beet-derived ingredients can enter the enterosalivary cycle. Oral bacteria convert nitrate into nitrite, which can be converted into nitric oxide under suitable physiological conditions. Whether the current Nitralis batch contains the same standardized nitrate quantity as products used in independent beetroot trials is not established from the publicly reviewed materials.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMagnesium ascorbate — a complementary biochemical rationale.\u003c\/strong\u003e Ascorbate (vitamin C) participates in the reduction of nitrite to nitric oxide in acidic gastric conditions. Pairing a beet-derived ingredient with an ascorbate source therefore has a plausible mechanistic rationale. The published trial did not isolate the effects of magnesium ascorbate, and the independently verified quantity of each constituent per serving remains an open product-documentation question. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12737438\/\" target=\"_blank\" rel=\"noopener\"\u003eRead the human gastric-juice research\u003c\/a\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEpimedium — a third complementary research direction.\u003c\/strong\u003e Epimedium constituents have been investigated in experimental vascular and PDE5-related signaling research, including an \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20416296\/\" target=\"_blank\" rel=\"noopener\"\u003eendothelial-cell study of isolated icariin\u003c\/a\u003e. They broaden the formula's mechanistic concept beyond nitrate delivery alone. Laboratory findings are not direct evidence that this blend treats erectile dysfunction or produces clinical effects in people.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhy the combination is interesting:\u003c\/strong\u003e These ingredients address different parts of a coherent nitric oxide support concept: a potential dietary nitrate source, an ascorbate-associated conversion mechanism and a botanical with experimental signaling research. That is a thoughtful formulation hypothesis. The trial assessed the blend as a whole; it did not prove that the ingredients are synergistic, establish how much each contributed or compare the trio against beetroot alone.\u003c\/p\u003e\n\u003ch2\u003eThe finished-formula randomized trial: the central reason to consider Nitralis\u003c\/h2\u003e\n\u003cp\u003eThe \u003ca href=\"https:\/\/biomedres.us\/fulltexts\/BJSTR.MS.ID.009914.php\" target=\"_blank\" rel=\"noopener\"\u003epublished 2025 pilot\u003c\/a\u003e included 85 adults assigned to Nitralis (43) or placebo (42) for 30 days. The study reports a median Day-30 increase of +90 semi-quantitative salivary strip units with Nitralis versus 0 with placebo, and 26 of 43 Nitralis participants met its response threshold versus 5 of 42 in the placebo group. The reported +226% figure was the mean percentage change in strip readings, not a directly measured increase in circulating nitric oxide.\u003c\/p\u003e\n\u003cp\u003eThose results are a positive early signal for the tested formulation. The report was funded by DoNotAge and its authors were affiliated with the manufacturer. It did not measure ambulatory blood pressure, endothelial function, exercise performance, erectile function or clinical disease outcomes. These are appropriate next endpoints for independent follow-up studies; they do not negate the observed trial's salivary findings.\u003c\/p\u003e\n\u003ch2\u003eStudy serving versus current product serving\u003c\/h2\u003e\n\u003cp\u003eThe trial report describes daily 400 mg capsules of the proprietary blend. The current DoNotAge product page states that each capsule contains 400 mg and recommends two capsules, or 800 mg daily. Follow the current retail label and discuss the product with a clinician if relevant. The equivalence of the study formulation and current batches—including separately standardized nitrate and botanical content—has not yet been independently confirmed. A larger label serving must not be assumed to produce twice the studied response.\u003c\/p\u003e\n\u003ch2\u003eProduct quality and practical use\u003c\/h2\u003e\n\u003cp\u003eDoNotAge markets Nitralis in capsule form and describes quality controls for its products. For the strongest batch-specific comparison, request the current certificate of analysis and confirm the measured active constituents, contaminant results and lot number. Packaging, prices, stock and promotions should be verified with the manufacturer at the time of purchase.\u003c\/p\u003e\n\u003ch2\u003eWho may wish to discuss it with a clinician?\u003c\/h2\u003e\n\u003cp\u003eNitralis may be of interest to adults who want a proprietary formula with published product-specific biomarker research and prefer a capsule rather than preparing nitrate-rich drinks. It is not a substitute for treating hypertension, erectile dysfunction or cardiovascular disease. Obtain personalized advice if you have low blood pressure, recent cardiac illness, kidney disease or are pregnant or breastfeeding, or if you take blood-pressure medicines or erectile-dysfunction medicines. Prescription organic nitrates and PDE5 inhibitors are an established dangerous combination; the interaction profile of Nitralis itself has not been fully studied.\u003c\/p\u003e\n\u003ch2\u003eOur take\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eNitralis is our featured branded nitric oxide support formula\u003c\/strong\u003e because its coherent three-ingredient concept is backed by a published placebo-controlled trial of the actual blend. We especially value that direct research link instead of assuming an attractive ingredient list guarantees a finished product works. The trial supports a salivary biomarker signal, and follow-up clinical-endpoint trials and current-batch confirmation will determine how broadly the findings translate.\u003c\/p\u003e\n\u003cp\u003e\u003csmall\u003eKey sources: \u003ca href=\"\/blogs\/research\/baily-2025-nitralis-salivary-no-trial\"\u003eNitralis pilot trial\u003c\/a\u003e; \u003ca href=\"\/blogs\/research\/norouzzadeh-2025-dietary-nitrate-dose-response-meta\"\u003edietary nitrate meta-analysis\u003c\/a\u003e; \u003ca href=\"\/blogs\/research\/babateen-2019-salivary-nitrite-strips-validity\"\u003esaliva-strip validation\u003c\/a\u003e.\u003c\/small\u003e\u003c\/p\u003e\n\u003c\/section\u003e","brand":"DoNotAge","offers":[{"title":"Default Title","offer_id":52576405291290,"sku":null,"price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1002\/8708\/6874\/files\/nitralis1000x1000.png?v=1788436970","url":"https:\/\/biohackblueprint.org\/products\/donotage-nitralis-review","provider":"Biohack Blueprint","version":"1.0","type":"link"}